Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
44.73
+1.25 (2.87%)
Nov 22, 2024, 4:00 PM EST - Market closed
Mirum Pharmaceuticals Market Cap
Mirum Pharmaceuticals has a market cap or net worth of $2.15 billion as of November 22, 2024. Its market cap has increased by 53.55% in one year.
Market Cap
2.15B
Enterprise Value
2.18B
1-Year Change
53.55%
Ranking
Category
Stock Price
$44.73
Market Cap Chart
Since July 18, 2019, Mirum Pharmaceuticals's market cap has increased from $297.23M to $2.15B, an increase of 622.43%. That is a compound annual growth rate of 44.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 2.10B | 52.42% |
| Dec 29, 2023 | 1.38B | 91.51% |
| Dec 30, 2022 | 718.54M | 47.79% |
| Dec 31, 2021 | 486.19M | -4.80% |
| Dec 31, 2020 | 510.71M | -7.70% |
| Dec 31, 2019 | 553.34M | 86.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Keros Therapeutics | 2.18B |
| Akero Therapeutics | 2.18B |
| Addus HomeCare | 2.17B |
| Premier | 2.15B |
| Amphastar Pharmaceuticals | 2.14B |
| Azenta | 2.07B |
| Astrana Health | 2.07B |
| Omnicell | 2.04B |